Pre-analytic variability in cardiovascular biomarker testing

Journal of Thoracic Disease

Volumn 7, Issue 10, 2015, Pages E395-E401

  Cemin, Roberto ^a   Daves, Massimo ^b  

^a CENTRAL HOSPITAL OF BOLZANO   (Italy)

^b Hospital of Merano   (Italy)

Author keywords

Biomarker; Cardiology; Laboratory variability

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; CARDIAC TROPONIN I; CARDIAC TROPONIN T; EDETIC ACID; NATRIURETIC FACTOR; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ANALYTICAL PARAMETERS; BLOOD SAMPLING; BODY POSITION; BODY POSTURE; CARDIOVASCULAR BIOMARKER TESTING; CENTRIFUGATION; CIRCADIAN RHYTHM; CLINICAL CHEMISTRY; COLLECTION DEVICE; DIET RESTRICTION; DISEASE ASSOCIATION; EXERCISE; GENERAL MEDICAL DEVICE; HEMOLYSIS; HUMAN; HYPERLIPIDEMIA; LABORATORY DIAGNOSIS; LABORATORY TEST; MOLECULAR STABILITY; PHYSICAL ACTIVITY; PRE ANALYTIC VARIABILITY; QUALITY CONTROL; REVIEW; SEX DIFFERENCE; SYSTEMATIC ERROR;

EID: 84947442742     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2015.10.03     Document Type: Review

References (72)

1. Clerico A. The increasing impact of laboratory medicine on clinical cardiology. Clin Chem Lab Med 2003;41:871-83.
2. Clerico A, Passino C, Franzini M, et al. Cardiac biomarker testing in the clinical laboratory: where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. Clin Chim Acta 2015;443:17-24.
3. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J 2012;33:2551-67.
4. Jarolim P. High sensitivity cardiac troponin assays in the clinical laboratories. Clin Chem Lab Med 2015;53:635-52.
5. Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2999-3054.
6. Newby LK, Jesse RL, Babb JD, et al. ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2012;60:2427-63.
7. Cowie MR, Mendez GF. BNP and congestive heart failure. Prog Cardiovasc Dis 2002;44:293-321.
8. Cemin R, Daves M, Panizza G, et al. Early cardiac risk stratification in obese patients: the need of new simple diagnostic tools. Mediterr J Nutr Metab 2012;5:227-31.
9. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33:1787-847.
10. Lippi G, Mattiuzzi C, Favaloro EJ. Pre-analytical variability and quality of diagnosis testing. Looking at the moon and gazing beyond the finger. N Z J Med Lab Sci 2015;69:4-8.
11. Lippi G, Guidi GC, Mattiuzzi C, et al. Preanalytical variability: the dark side of the moon in laboratory testing. Clin Chem Lab Med 2006;44:358-65.
12. Lippi G, Banfi G, Buttarello M, et al. Recommendations for detection and management of unsuitable samples in clinical laboratories. Clin Chem Lab Med 2007;45:728-36.
13. Lippi G, Becan-McBride K, Behúlová D, et al. Preanalytical quality improvement: in quality we trust. Clin Chem Lab Med 2013;51:229-41.
14. Lima-Oliveira G, Lippi G, Salvagno GL, et al. New ways to deal with known preanalytical issues: use of transilluminator instead of tourniquet for easing vein access and eliminating stasis on clinical biochemistry. Biochem Med (Zagreb) 2011;21:152-9.
15. Lippi G, Plebani M. Primary blood tubes mixing: time for updated recommendations. Clin Chem Lab Med 2012;50:599-600.
16. Adcock Funk DM, Lippi G, Favaloro EJ. Quality standards for sample processing, transportation, and storage in hemostasis testing. Semin Thromb Hemost 2012;38:576-85.
17. Lippi G, Salvagno GL, Montagnana M, et al. Influence of the centrifuge time of primary plasma tubes on routine coagulation testing. Blood Coagul Fibrinolysis 2007;18:525-8.
18. Daves M, Giacomuzzi K, Tagnin E, et al. Influence of centrifuge brake on residual platelet count and routine coagulation tests in citrated plasma. Blood Coagul Fibrinolysis 2014;25:292-5.
19. Bowen RA, Remaley AT. Interferences from blood collection tube components on clinical chemistry assays. Biochem Med (Zagreb) 2014;24:31-44.
20. Daves M, Trevisan D, Cemin R. Different collection tubes in cardiac biomarkers detection. J Clin Lab Anal 2008;22:391-4.
21. Lippi G, Daves M, Mattiuzzi C. Interference of medical contrast media on laboratory testing. Biochem Med (Zagreb) 2014;24:80-8.
22. Daves M, Lippi G, Cosio G, et al. An unusual case of a primary blood collection tube with floating separator gel. J Clin Lab Anal 2012;26:246-7.
23. Simundic AM, Cornes M, Grankvist K, et al. Standardization of collection requirements for fasting samples: for the Working Group on Preanalytical Phase (WG-PA) of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). Clin Chim Acta 2014;432:33-7.
24. Lima-Oliveira G, Salvagno GL, Lippi G, et al. Influence of a regular, standardized meal on clinical chemistry analytes. Ann Lab Med 2012;32:250-6.
25. Lima-Oliveira G, Salvagno GL, Lippi G, et al. Could light meal jeopardize laboratory coagulation tests? Biochem Med (Zagreb) 2014;24:343-9.
26. Lippi G, Lima-Oliveira G, Salvagno GL, et al. Influence of a light meal on routine haematological tests. Blood Transfus 2010;8:94-9.
27. Nikolac N. Lipemia: causes, interference mechanisms, detection and management. Biochem Med (Zagreb) 2014;24:57-67.
28. Saracevic A, Nikolac N, Simundic AM. The evaluation and comparison of consecutive high speed centrifugation and LipoClear® reagent for lipemia removal. Clin Biochem 2014;47:309-14.
29. Sanchis-Gomar F, Lippi G. Physical activity-an important preanalytical variable. Biochem Med (Zagreb) 2014;24:68-79.
30. Scharhag J, Herrmann M, Urhausen A, et al. Independent elevations of N-terminal pro-brain natriuretic peptide and cardiac troponins in endurance athletes after prolonged strenuous exercise. Am Heart J 2005;150:1128-34.
31. Nie J, Tong TK, George K, et al. Resting and post-exercise serum biomarkers of cardiac and skeletal muscle damage in adolescent runners. Scand J Med Sci Sports 2011;21:625-9.
32. Lippi G, Cervellin G, Banfi G, et al. Cardiac troponins and physical exercise. It's time to make a point. Biochem Med (Zagreb) 2011;21:55-62.
33. Lippi G, Schena F, Salvagno GL, et al. Comparison of conventional and highly-sensitive troponin I measurement in ultra-marathon runners. J Thromb Thrombolysis 2012;33:338-42.
34. Nie J, Tong TK, Shi Q, et al. Serum cardiac troponin response in adolescents playing basketball. Int J Sports Med 2008;29:449-52.
35. Shave R, Ross P, Low D, et al. Cardiac troponin I is released following high-intensity short-duration exercise in healthy humans. Int J Cardiol 2010;145:337-9.
36. Tjora S, Gjestland H, Mordal S, et al. Troponin rise in healthy subjects during exercise test. Int J Cardiol 2011;151:375-6.
37. Savukoski T, Mehtälä L, Lindahl B, et al. Elevation of cardiac troponins measured after recreational resistance training. Clin Biochem 2015;48:803-6.
38. Salvagno GL, Schena F, Gelati M, et al. The concentration of high-sensitivity troponin I, galectin-3 and NT-proBNP substantially increase after a 60-km ultramarathon. Clin Chem Lab Med 2014;52:267-72.
39. Lippi G, Schena F, Salvagno GL, et al. Influence of a half-marathon run on NT-proBNP and troponin T. Clin Lab 2008;54:251-4.
40. Lippi G, Salvagno GL, Lima-Oliveira G, et al. Circulating cardiac troponin T is not influenced by postural changes during venous blood collection. Int J Cardiol 2014;177:1076-7.
41. Klinkenberg LJ, van Dijk JW, Tan FE, et al. Circulating cardiac troponin T exhibits a diurnal rhythm. J Am Coll Cardiol 2014;63:1788-95.
42. Eggers KM, Lind L, Venge P, et al. Factors influencing the 99th percentile of cardiac troponin I evaluated in community-dwelling individuals at 70 and 75 years of age. Clin Chem 2013;59:1068-73.
43. Aw TC, Phua SK, Tan SP. Measurement of cardiac troponin I in serum with a new high-sensitivity assay in a large multi-ethnic Asian cohort and the impact of gender. Clin Chim Acta 2013;422:26-8.
44. Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 2012;58:1574-81.
45. Franzini M, Lorenzoni V, Masotti S, et al. The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: a multicenter study in Italy. Clin Chim Acta 2015;438:376-81.
46. Gerhardt W, Nordin G, Herbert AK, et al. Troponin T and I assays show decreased concentrations in heparin plasma compared with serum: lower recoveries in early than in late phases of myocardial injury. Clin Chem 2000;46:817-21.
47. Wang YS, Feng CF, Er TK, et al. Comparison of cardiac troponin I levels in serum and sodium-citrate plasma using the ACCESS 2 immunoassay. Ann Clin Lab Sci 2005;35:453-4.
48. Daves M, Pusceddu I, Cemin R. Measurement of Type B natriuretic peptide in heparin and K(2) EDTA plasma. Clin Biochem 2010;43:483-4.
49. Lippi G, Fortunato A, Salvagno GL, et al. Influence of sample matrix and storage on BNP measurement on the Bayer Advia Centaur. J Clin Lab Anal 2007;21:293-7.
50. Dupuy AM, Terrier N, Dubois M, et al. Heparin plasma sampling as an alternative to EDTA for BNP determination on the Access-Beckman Coulter-effect of storage at-20 degrees C. Clin Lab 2006;52:393-7.
51. Wu AH, Packer M, Smith A, et al. Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study. Clin Chem 2004;50:867-73.
52. Yeo KT, Wu AH, Apple FS, et al. Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta 2003;338:107-15.
53. Thomas L. Haemolysis as influence and interference factor. eJIFCC vol 13 no 4. Available online: http://www.ifcc.org/ejifcc/vol13no4/130401002.htm
54. Lippi G, Guidi GC. Risk management in the preanalytical phase of laboratory testing. Clin Chem Lab Med 2007;45:720-7.
55. Bonini P, Plebani M, Ceriotti F, et al. Errors in laboratory medicine. Clin Chem 2002;48:691-8.
56. Carraro P, Servidio G, Plebani M. Hemolyzed specimens: a reason for rejection or a clinical challenge? Clin Chem 2000;46:306-7.
57. Lippi G, Blanckaert N, Bonini P, et al. Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin Chem Lab Med 2008;46:764-72.
58. Selby C. Interference in immunoassay. Ann Clin Biochem 1999;36:704-21.
59. Wenk RE. Mechanism of interference by hemolysis in immunoassays and requirements for sample quality. Clin Chem 1998;44:2554.
60. Lippi G, Salvagno GL, Montagnana M, et al. Influence of hemolysis on routine clinical chemistry testing. Clin Chem Lab Med 2006;44:311-6.
61. Lippi G, Montagnana M, Salvagno GL, et al. Interference of blood cell lysis on routine coagulation testing. Arch Pathol Lab Med 2006;130:181-4.
62. Lyon ME, Ball CL, Krause RD, et al. Effect of hemolysis on cardiac troponin T determination by the Elecsys 2010 immunoanalyzer. Clin Biochem 2004;37:698-701.
63. Sodi R, Darn SM, Davison AS, et al. Mechanism of interference by haemolysis in the cardiac troponin T immunoassay. Ann Clin Biochem 2006;43:49-56.
64. Masimasi N, Means RT Jr. Elevated troponin levels associated with hemolysis. Am J Med Sci 2005;330:201-3.
65. Daves M, Salvagno GL, Cemin R, et al. Influence of hemolysis on routine laboratory cardiac marker testing. Clin Lab 2012;58:333-6.
66. Bais R. The effect of sample hemolysis on cardiac troponin I and T assays. Clin Chem 2010;56:1357-9.
67. Florkowski C, Wallace J, Walmsley T, et al. The effect of hemolysis on current troponin assays-a confounding preanalytical variable? Clin Chem 2010;56:1195-7.
68. Snyder JA, Rogers MW, King MS, et al. The impact of hemolysis on Ortho-Clinical Diagnostic's ECi and Roche's elecsys immunoassay systems. Clin Chim Acta 2004;348:181-7.
69. Gobinet-Georges A, Valli N, Filliatre H, et al. Stability of brain natriuretic peptide (BNP) in human whole blood and plasma. Clin Chem Lab Med 2000;38:519-23.
70. Mueller T, Gegenhuber A, Dieplinger B, et al. Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples. Clin Chem Lab Med 2004;42:942-4.
71. Daves M, Cemin R. Type B natriuretic peptide stability in frozen plasma. Clin Chem Lab Med 2007;45:1257-8.
72. Pereira M, Azevedo A, Severo M, et al. Long-term stability of endogenous B-type natriuretic peptide during storage at-20 degrees C for later measurement with Biosite Triage assay. Clin Biochem 2007;40:1104-7.